AEO audit pricing for pharma brands is driven by scope, not vendor-set flat rates. The levers are platforms covered, buyer-question depth, and whether competitive benchmarking is included. AEO Dose offers a Free Check at $0 covering 2 platforms and 10 questions; Full Audit pricing is scoped per engagement, not listed publicly. No credible public benchmark exists yet.

Why there is no public price list for AEO services (and why that is honest)

There is no public price benchmark for AEO services yet, and that absence is itself a signal about how early this market is. Most SaaS tools publish a pricing page because the product is standardized: you pay for seats or usage tiers, and the deliverable is the same for every buyer. AEO work does not fit that mold. It is diagnostic, not subscription-based, which means the deliverable changes with the question being asked.

When you ask how an API manufacturer appears in a ChatGPT answer, the work required to find out depends entirely on what you want to know. That is why most AEO work is still custom-scoped. A buyer scanning for a flat rate is applying a SaaS expectation to a diagnostic service, and the two do not map. The honest version of a price answer is not a number. It is a description of what the number would have to cover.

For readers newer to the category, it helps to understand what AEO actually involves before judging its cost. The work of AI Answer Engine Optimization and how it differs from traditional SEO is covered in more depth across the Understanding AI Visibility and AEO cluster, and it explains why this is a measurement-and-diagnosis exercise rather than a software subscription.

The real cost drivers: platforms, question depth, benchmarking, and implementation support

Four factors move an AEO quote, and each one works through a concrete mechanism rather than a markup. Understanding the mechanism lets you read a quote instead of guessing at it.

Platforms covered. AEO Dose tests against five AI assistants: ChatGPT, Gemini, Perplexity, Claude, and Grok. Each one retrieves and ranks sources differently, so each must be tested separately. You cannot pull all five from a single dashboard. When a quote covers two platforms, the testing effort is smaller than when it covers five. The price reflects that difference in effort, not a vendor's margin preference.

Buyer-question depth. An audit tests how you appear when a buyer asks a specific question. Ten buyer questions is a narrower probe than a full question set covering sourcing, compliance, capacity, and comparison prompts. When a quote includes more questions, more prompts get run and more answers get analyzed. Depth is a direct driver of effort.

Competitive benchmarking. Benchmarking tests not just whether you appear, but how you appear relative to the suppliers an AI names alongside or instead of you. When a quote includes benchmarking, the analyst is running the same prompts against your competitive set and comparing outputs. In the absence of benchmarking, you learn your own visibility but not your position.

Implementation support. A diagnosis tells you where the gaps are. Implementation support acts on them. When a quote includes support beyond the audit itself, it covers work the audit only identifies.

What a free entry point looks like in practice

A free entry point is a genuine diagnostic, not a teaser. The AEO Dose Free AI Visibility Check costs $0 and covers 2 platforms and 10 buyer questions. It shows you how your business surfaces when a buyer asks an AI assistant a handful of the questions that matter in your segment.

The point of a $0 check is to let a pharma buyer see what an audit produces before committing budget to a larger one. You get a concrete read on your current visibility across two platforms. The distinction between what the Free Check covers and what the Full Audit covers is explained further in the Audit and Optimization Process cluster, which walks through the audit, optimize, build authority, measure, repeat cycle. The Free Check is the honest front door to that cycle.

What a full audit adds and why the delta matters for pharma buyers

A full audit adds platform breadth, question depth, and competitive benchmarking, and for pharma buyers the benchmarking is where the delta earns its place. The Full AI Visibility and AEO Readiness Audit covers all five platforms with competitive benchmarking included, against the Free Check's two platforms and ten questions.

That delta matters because pharma buyers do not shop in isolation. When a procurement lead asks an AI assistant to recommend or compare suppliers, the answer names a set. Knowing only your own visibility tells you half the story. Benchmarking tells you whether the assistant surfaces you, a competitor, or no one credible at all when the prompt is a real sourcing question. For a regulated supplier where a single named recommendation can shape a shortlist, that is the difference between a vanity check and a decision-grade read. The founder's background in Pharma ERP and Computer System Validation shapes how these buyer questions get framed, so the prompts reflect how procurement actually asks rather than how marketing imagines it.

How business type (API, CDMO, excipient, nutraceutical, oral care) shifts scope

Business type shifts scope because the buyer questions that matter are different for each segment, and the questions define the audit. An API manufacturer and an oral care brand are surfaced by AI assistants in response to entirely different prompts.

A CDMO gets tested against prompts about solid dose capacity, regulatory track record, and development services. An excipient supplier gets tested against prompts about functionality, grades, and regulatory documentation. A nutraceutical brand gets tested against prompts where it may be cited without a link at all. Because the relevant prompt set differs, the audit scope differs, and the price follows the scope. The ways these segments appear in AI answers are explored across the Industry-Specific Visibility Challenges cluster, which details why a CDMO, an excipient supplier, and a nutraceutical brand each face a distinct visibility problem that a generic audit would miss.

Reading an AEO quote: what to compare line by line

Comparing AEO quotes means comparing scope line by line, because two quotes with different numbers may simply be pricing different amounts of work. A lower number is not a better deal if it covers two platforms where you needed five.

Ask what each quote actually includes. How many platforms, and which ones? How many buyer questions, and are they relevant to your segment? Is competitive benchmarking in or out? Does the engagement include implementation support or stop at diagnosis? Is there a long-term contract attached, or is the work scoped as a discrete diagnostic? When two quotes differ in price, the honest explanation is a difference in these lines rather than a difference in vendor quality. Readers who want a deeper framework for this will find it in the Comparing AI Visibility Services cluster, which goes line by line through how to evaluate platform-coverage claims and scope.

A practical next step before you request a quote

A useful action to take this week is to run the Free AI Visibility Check before you request any paid quote. It costs nothing, covers two platforms and ten buyer questions, and gives you a concrete read on your current visibility.

That read becomes your scoping tool. Once you see where you are absent, mis-cited, or outranked by a competitor on the questions that matter, you can scope a Full Audit against the specific gaps the Free Check exposes rather than against a vendor's standard package. You will read any subsequent quote with a clear sense of which platforms and which questions you actually need covered. Start there.

Get Your Free AI Visibility Check

Start for Free

Frequently asked questions

What determines the cost of an AEO audit for a pharma business?

Cost follows scope. Three levers move the price: how many AI platforms are tested, how many buyer questions are run, and whether competitive benchmarking is included. A narrow probe of two platforms and ten questions requires less analyst effort than a five-platform audit with benchmarking against your competitive set. Business segment also shifts scope, because an API manufacturer and a nutraceutical brand get tested against entirely different buyer prompts. There is no flat rate because the deliverable changes with the questions you want answered.

Is there a free option to test AI visibility before paying for a full audit?

Yes. AEO Dose offers a Free AI Visibility Check at $0 that covers two platforms and ten buyer questions. It is a genuine diagnostic, not a teaser, and it shows you how your business surfaces when a buyer asks an AI assistant the kind of questions that matter in your segment. The intent is to let you see what an audit produces before committing budget to a larger one, which also makes it a practical scoping tool for any paid engagement you consider afterward.

Why do AEO services not have fixed public price lists like SaaS tools?

Because AEO work is diagnostic rather than subscription-based. Most SaaS tools publish a price list because the product is standardized across every buyer. AEO work changes with the question being asked: the platforms, the buyer prompts, and the competitive set all differ by engagement. A flat public rate would misrepresent work that is custom-scoped by design. The honest version of a price answer describes what the number would have to cover rather than quoting a figure that cannot hold across different scopes.

How does platform coverage change the price?

Each AI assistant retrieves and ranks sources differently, so each must be tested separately. AEO Dose tests against ChatGPT, Gemini, Perplexity, Claude, and Grok. You cannot pull all five from one dashboard, which means a five-platform audit carries more testing effort than a two-platform check. Platform coverage is a direct cost mechanism: more platforms mean more separate tests and more analysis. When you read a quote, confirm which specific platforms are covered, not just how many.

What does competitive benchmarking add to an audit?

Benchmarking tests how you appear relative to the suppliers an AI assistant names alongside or instead of you, not just whether you appear at all. When benchmarking is included, the same buyer prompts are run against your competitive set and the outputs are compared. For pharma buyers this matters because a procurement lead asking an AI to compare suppliers gets a set of names back. Without benchmarking you learn your own visibility but not your position within that set, which is a decision-relevant gap in the read.

What should pharma buyers watch for in an AEO services quote?

Compare scope line by line. Check how many platforms and which specific ones, how many buyer questions and whether they fit your segment, whether competitive benchmarking is in or out, and whether the engagement includes implementation support or stops at diagnosis. Also check whether a long-term contract is attached or the work is a discrete diagnostic. A lower number is not a better deal if it covers less of what you actually need. Price differences trace to scope differences in these lines rather than to vendor quality.